Epilepsy Surgery Market size was valued at US$ 1.07 Bn. in 2022 and the total revenue is expected to grow at 6.10% through 2023 to 2029, reaching nearly US$ 1.63 Bn.Epilepsy Surgery Market Overview:
Epilepsy surgery is a type of neurosurgery that involves treating the parts of the brain that cause seizures. The operation is performed in order to lessen or eliminate the risk of seizures. The rise of the epilepsy surgery market can be ascribed to the rising incidence of neurological disorders, which has resulted in substantial research and development on epilepsy treatment devices, as well as an increase in the number of cases of brain injuries caused by car accidents. Technological advancements in robot-assisted surgery, as well as an increase in the geriatric population, are expected to fuel market growth. Risks connected with epilepsy surgery, on the other hand, may limit market expansion.To know about the Research Methodology :- Request Free Sample Report
Epilepsy Surgery Market Dynamics:
Epilepsy affects roughly 50 million people worldwide, according to the WHO's 2019 fact sheets, making it one of the most frequent neurological diseases. Epilepsy affects about 80% of people in low- and middle-income nations. If properly diagnosed and treated, it is believed that up to 70% of persons with epilepsy could live seizure-free. After migraines, strokes, and Alzheimer's disease, epilepsy is the fourth most frequent neurological condition. In 2015, the Centers for Disease Control and Prevention (CDC) anticipated that 1.3 % of the US population (3.4 million) had active epilepsy this factor further motivated the epilepsy surgery market. Adult epileptic patients at the University of Gondar Referral Hospital in Ethiopia were evaluated in a study published in Sage Open Medicine in 2018. A total of 79 adverse events were reported as a result of the drug, including exhaustion and gastrointestinal disturbance. Anticonvulsants, often known as antiepileptic medicines, are a class of pharmacological compounds that are used to treat epileptic seizures. The epilepsy surgery market is being bolstered by the increasing deployment of helper robots for efficient and accurate surgical planning and navigation. Patients choose minimally invasive procedures because they have a lower risk of complications, better patient outcomes, and a shorter recovery period. To remove epilepsy diseases, epilepsy surgery requires equipment such as stereo electro encephalography (SEEG), biopsy, thermal ablation of seizure foci or tumors, and deep brain stimulation (DBS). Furthermore, before the adoption of computer-guided robotic arms adopted from the automobile sector for neurosurgery use, specialized stereotactic frames were used. SEEG is a collaborative effort between neurologists and neurosurgeons to design a basic strategy based on a noninvasive presurgical epilepsy workup. A typical 10-electrode montage can yield more than 150 recording locations. In the pediatric population, robotic stereotactic aid for neurosurgery has been documented occasionally.Epilepsy Surgery Market Segment Analysis:
The Laser Interstitial Thermal Therapy (LITT) segment is dominating the Procedure Type segment of the Epilepsy Surgery Market: LITT (Laser Interstitial Thermal Therapy) is a minimally invasive procedure for treating drug-resistant epilepsy and seizures that are unresponsive to medication. LITT may help some people with focal seizures that originate in a single area of the brain. The LITT procedure usually takes three to four hours. Ablation of neurological soft tissue is now possible thanks to the development of MRI-guided LITT systems. Respective surgery is likely to grab a significant growth of the Epilepsy Market in the forecast timeframe. A little piece of the brain is removed during resective surgery. The surgeon removes brain tissue from the area of the brain where seizures occur, which is frequently a tumor, brain damage, or abnormality. It is the most often performed epilepsy surgery. Around 70% of persons who have temporal lobe surgery say that it ends their seizures. Additionally, 20% report a reduction in the frequency of their seizures. Despite being on one year of medication with an acceptable dose of antiepileptic medicine, epilepsy surgery is recommended in 30% to 40% of individuals with refractory seizure disorders. The Hospital and Clinics segment is considered to supplement the growth of the Epilepsy Surgery Market. In terms of end-users, hospitals and clinics dominate the epilepsy surgery market. This increase is primarily due to an increase in the number of people being diagnosed with epilepsy and receiving epilepsy surgery. Patients choose to be treated in the hospital because advanced and comprehensive treatments are offered. Clinics are also medical care facilities that treat epilepsy patients. Europe, the Americas, and developing countries such as India, China, and Russia are among the countries with the most hospitals giving treatment for this disease. Moreover, the rise in industrialization, growing population, and increasing per capita income are the factors boosting the expansion of hospitals and clinics in the forecast period.Epilepsy Surgery Market Regional Insights:
North America is likely to boost the growth of the Epilepsy Surgery Market. Due to a variety of elements, including the availability of well-established healthcare facilities, the high prevalence of neurological illnesses, and the rising incidence of epilepsy, the Americas dominated the epilepsy surgery market. The US. and Canada are the major countries of North America. A central nervous system (CNS) illness, which produces seizures and is the fourth most prevalent neurological disease, is believed to affect approximately 150,000 Americans. The incidence rate is also observed to be highest in small children under the age of two and individuals aged 65 and over. Epilepsy is becoming more common in the Americas. Seizures afflict around 300,000 Canadians, and one in every 2,000 persons is diagnosed with epilepsy each year. In the Canadian population, neurological illnesses are also among the top causes of disability. The objective of the report is to present a comprehensive analysis of the Epilepsy Surgery Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Epilepsy Surgery Market dynamics, structure by analyzing the market segments and project the Epilepsy Surgery Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Epilepsy Surgery Market make the report investor’s guide.Epilepsy Surgery Market Scope: Inquire before buying
Global Epilepsy Surgery Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.07 Bn. Forecast Period 2023 to 2029 CAGR: 6.10% Market Size in 2029: US $ 1.63 Bn. Segments Covered: by Procedure Type Resective Surgery Laser Interstitial Thermal Therapy (LITT), Other by End-User Hospitals & Clinics Specialty Centers Epilepsy Surgery Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Epilepsy Surgery Market Key Player
1.Novartis AG 2.Pfizer Incorporated 3.Glaxo Smith Kline Plc 4.Stryker (US) 5.Zimmer Biomet Holdings Inc. (US) 6.Auris Health, Inc. (Hansen Medical, Inc.) (US) 7.Intuitive Surgical (US) 8.Medtronic Plc (Mazor Robotics) (Ireland) 9.Cephalon, Inc. (US) 10.CMR Surgical (UK) 11.Natus Medical Incorporated (US) 12.Livanova Plc (UK) 13.Monteris Medical (US) 14.Pfizer, Inc. 15.UCB S.A 16.Bausch Health Companies Inc. 17.Teva Pharmaceutical Industries Ltd. 18.Sunovion Pharmaceuticals Inc.Frequently Asked Questions:
1. Which region has the largest share in Global Epilepsy Surgery Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Epilepsy Surgery Market? Ans: The Global Epilepsy Surgery Market is expected to grow at a CAGR of 6.10% during forecast period 2023-2029. 3. What is scope of the Global Epilepsy Surgery market report? Ans: Global Epilepsy Surgery Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Epilepsy Surgery market? Ans: The important key players in the Global Epilepsy Surgery Market are – , Novartis AG, Pfizer Incorporated, Glaxo Smith Kline Plc, Stryker (US), Zimmer Biomet Holdings Inc. (US), Auris Health, Inc. (Hansen Medical, Inc.) (US), Intuitive Surgical (US), Medtronic Plc (Mazor Robotics) (Ireland), Cephalon, Inc. (US), CMR Surgical (UK), Natus Medical Incorporated (US), Livanova Plc (UK), Monteris Medical (US), Pfizer, Inc., UCB S.A, Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., and Sunovion Pharmaceuticals Inc. 5. What is the study period of this market? Ans: The Global Epilepsy Surgery Market is studied from 2022 to 2029.
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Epilepsy Surgery Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Epilepsy Surgery Market 3.4. Geographical Snapshot of the Epilepsy Surgery Market, By Manufacturer share 4. Epilepsy Surgery Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Epilepsy Surgery Market 5. Supply Side and Demand Side Indicators 6. Epilepsy Surgery Market Analysis and Forecast, 2022-2029 6.1. Epilepsy Surgery Market Size & Y-o-Y Growth Analysis. 7. Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 7.1.1. Resective Surgery 7.1.2. Laser Interstitial Thermal Therapy (LITT), 7.1.3. Other 7.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 7.2.1. Hospitals & Clinics 7.2.2. Specialty Centers 8. Epilepsy Surgery Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 9.1.1. Resective Surgery 9.1.2. Laser Interstitial Thermal Therapy (LITT), 9.1.3. Other 9.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 9.2.1. Hospitals & Clinics 9.2.2. Specialty Centers 10. North America Epilepsy Surgery Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 12. Canada Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 13. Mexico Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 14. Europe Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 15. Europe Epilepsy Surgery Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 17. France Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 18. Germany Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 19. Italy Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 20. Spain Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 21. Sweden Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 22. CIS Countries Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 23. Rest of Europe Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 24. Asia Pacific Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 25. Asia Pacific Epilepsy Surgery Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 27. India Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 28. Japan Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 29. South Korea Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 30. Australia Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 31. ASEAN Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 32. Rest of Asia Pacific Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 33. Middle East Africa Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 34. Middle East Africa Epilepsy Surgery Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 36. GCC Countries Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 37. Egypt Textile Reinforced Concrete e-Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 38. Nigeria Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 39. Rest of ME&A Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 40. South America Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 41. South America Epilepsy Surgery Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 43. Argentina Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 44. Rest of South America Epilepsy Surgery Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Procedure Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Epilepsy Surgery Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Pfizer (Hospira) 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. Stryker (US) 45.3.3. Zimmer Biomet Holdings Inc. (US) 45.3.4. Auris Health, Inc. (Hansen Medical, Inc.) (US) 45.3.5. Intuitive Surgical (US) 45.3.6. Medtronic Plc (Mazor Robotics) (Ireland) 45.3.7. Cephalon, Inc. (US) 45.3.8. CMR Surgical (UK) 45.3.9. Natus Medical Incorporated (US) 45.3.10. Livanova Plc (UK) 45.3.11. Monteris Medical (US) 45.3.12. Pfizer, Inc. 45.3.13. UCB S.A 45.3.14. Bausch Health Companies Inc. 45.3.15. Novartis AG 45.3.16. GlaxoSmithKline plc. 45.3.17. Teva Pharmaceutical Industries Ltd. 45.3.18. Sunovion Pharmaceuticals Inc. 46. Primary Key Insights